Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder known to affect the nervous system by direct neuronal damage, vasculitis, or pathologic mechanisms indirectly induced by immune mechanisms related to the production and deposition of immune complexes. SLE has a wide range of clinical manifestations due to the involvement of almost every organ system of the body. SLE presents with serositis, mucositis, arthralgia, glomerulopathy, hematological, cutaneous, and hematological manifestations. Among the neurological manifestations of SLE, posterior reversible encephalopathy is rarely described in the literature. We report a case of posterior reversible encephalopathy in a female patient who presented with seizures, altered mentation, headache, and blurry vision in the setting of undiagnosed SLE.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418817PMC
http://dx.doi.org/10.7759/cureus.16945DOI Listing

Publication Analysis

Top Keywords

posterior reversible
12
reversible encephalopathy
12
systemic lupus
8
lupus erythematosus
8
sle
5
encephalopathy undiagnosed
4
undiagnosed systemic
4
erythematosus rare
4
rare case
4
case report
4

Similar Publications

Background: This study quantified tau binding in the brain with F-PI2620 PET using a non-invasive Image-Derived Input function(IDIF), derived using a new total-body EXPLORER PET/CT scanner (Spencer et al.,2021). Additionally, we explored how PET scan duration influences the quantification of kinetic parameters across brain regions of interest(ROIs) that are vulnerable in Alzheimer's Disease.

View Article and Find Full Text PDF

Background: PET imaging studies examining amyloid-β plaques and tau neurofibrillary tangles, concurrent with cognitive testing, give insight into in vivo Alzheimer's Disease (AD) pathology burden and corresponding clinical outcomes. Braak stages IV-VI indicate advanced tau aggregation in the association and primary cortices associated with AD neuropathological changes which are often accompanied by cognitive decline or impairment. Not all individuals with AD pathological changes present with the expected rate of cognitive decline or standard Braak staging progression, such as in cases of resilience or posterior cortical atrophy (PCA), a variant of AD identified by parieto-occipital tau aggregation.

View Article and Find Full Text PDF

Background: This study quantified tau binding in the brain with 18F-PI2620 PET using a non-invasive Image-Derived Input function(IDIF), derived using a new total-body EXPLORER PET/CT scanner (Spencer et al.,2021). Additionally, we explored how PET scan duration influences the quantification of kinetic parameters across brain regions of interest(ROIs) that are vulnerable in Alzheimer's Disease.

View Article and Find Full Text PDF

Alzheimer's Imaging Consortium.

Alzheimers Dement

December 2024

Siemens Heathineers, Princeton, NJ, USA.

Background: The recent breakthrough in monoclonal antibody treatment for Alzheimer's disease (AD) has ushered in a new phase in AD healthcare. However, associated amyloid-related imaging abnormalities (ARIA) present a significant risk to patients, necessitating careful monitoring. Detection by radiologists can be challenging and may suffer from inconsistency.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.

Background: Responses to individualized music in people living with dementia can be indicated by both verbal and non-verbal cues. Evidence suggests that elevated pupil dilation responses to familiar vs. unfamiliar music are preserved in people living with typical Alzheimer's disease (tAD), and to an extent in people with its atypical 'visual' variant (Posterior Cortical Atrophy; PCA) (Brotherhood et al.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!